Mandatory HPV vaccination

JAMA

Volumn 307, Issue 3, 2012, Pages 254-

  Tomljenovic, Lucija ^a   Shaw, Christopher A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AUTOIMMUNE DISEASE; CANCER MORTALITY; CANCER PREVENTION; CLINICAL EFFECTIVENESS; DNA VIRUS INFECTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; LETTER; MANDATORY PROGRAM; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UTERINE CERVIX CANCER; VACCINATION; VACCINATION REACTION; VOLUNTARY PROGRAM; WART VIRUS; WOMEN'S HEALTH; FEMALE; LEGAL ASPECT; MALE; NOTE; POLICY; POLITICS;

FEMALE; HUMANS; MALE; MANDATORY PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POLITICS; PUBLIC POLICY; VACCINATION;

EID: 84856012470     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.2020     Document Type: Letter

References (5)

1. Gostin LO. Mandatory HPV vaccination and political debate. JAMA. 2011;306(15):1699-1700.
2. Tomljenovic L, Shaw AE. Human papillomavirus (HPV) vaccine policy and evidence- based medicine: are they at odds? Ann Med. doi:10.3109/07853890.2011. 645353.
3. Harper DM, Williams KB. Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies. Discov Med. 2010;10(50):7-17.
4. Food and Drug Administration (FDA). Gardasil (human papillomavirus vaccine) questions and answers-June 8, 2006. http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm. Accessed September 27, 2011.
5. WHO/ICO Information Centre on Human Papilloma Virus and Cervical Cancer. What is the impact of cervical cancer in your country? http://apps.who.int/ hpvcentre/statistics/dynamic/ico/SummaryReportsSelect.cfm. Accessed September 27, 2011.